ABSTRACT
The effect of Nono (a Nigerian fermented milk) on diabetic situation in rats, induced by intraperitonial injection of alloxan monohydrate is reported. Nono administration for 4 weeks lowered the raised plasma glucose concentration of diabetic rats; restoring it to the non diabetic rat level. The low tissue protein and raised plasma protein concentrations; hyperlipidemia; and hypercholesterolemia consequential on diabetic induction were reversed to the normal level by the Nono administration. The reversals of these effects of diabetes may be due to the lowering of the plasma glucose concentration by Nono or direct activity of either the bacteria or milk components of Nono on these substances. The results indicate that consumption of Nono produced by wild strain lactic acid bacteria may be helpful in the management of diabetes.
PDF Abstract XML References Citation
How to cite this article
DOI: 10.3923/ajft.2008.394.398
URL: https://scialert.net/abstract/?doi=ajft.2008.394.398
INTRODUCTION
Interest in the health implications of fermented foods has continued to be on the increase. Aderiye and Laleye (2003) reported that in Nigeria, these foods are employed as alternative methods of treatment for diahorrea, dysentery and common stomach upsets even before affected individuals seek professional medical attention. Such Nigerian fermented foods include Ogi from maize, Fufu, Gari from cassava, Nono from milk and Iru from locust beans.
There are numerous reports of fermented milk products having probiotic effect. Most researched is the hypocholesterolemic effect. For example, Akalin et al. (1997) and Laleye et al. (2007) have reported the hypocholesterolemic effects of Lactic Acid Bacteria (LAB) fortified yoghourt in mice; and of Nono, a Nigerian fermented milk product in albino rats respectively. These hypocholesterolemic effects have been credited to the LAB or bifidobacteria component of fermented milk (Tabuchi et al., 2003a; Abd El-Gawad et al., 2005; Laleye et al., 2007).
The probiotic effect of fermented foods is being examined over a wider range of diseases. Laleye (2007) has suggested that LAB containing fermented foods such as Ogi and Nono can be employed in the management of chronic metabolic disorder such as diabetes mellitus. Tabuchi et al. (2003b) reported improved glucose tolerance in neonatally streptozotocin-induced diabetic rats when their foods were supplemented with Lactobacillus GG cells. Diabetes mellitus is a disease characterized by hyperglycemia resulting from defects in insulin secretion or action or both. This results in damage, dysfunction and failure of various organs especially the eyes, kidneys, heart and blood vessels. The management efforts include attempts at bringing down the hyperglycemia and consequently reverse the organ damage.
Literature on the use of Nigerian fermented foods/beverages in the management of chronic metabolic disorder is scanty. It is to this end that this study investigated the effect of the consumption of Nono (a Nigerian fermented milk product) on alloxan-induced diabetes in albino rats. Nono is a Nigerian fermented milk beverage obtained from natural fermentation of fresh cow milk, which results in a curdled and highly soured product that is widely consumed in Nigeria and the West African sub region (Akinyanju, 1989; Savadogo et al., 2004).
MATERIALS AND METHODS
The Nono used in this study was obtained from a single local producer in rural Nigeria. This was to ensure reasonable consistency of the product. The LAB population of each sample purchased was assayed for by the pour plate method employing MRS agar with incubation in a microaerophilic condition at 37°C.
Weaned albino rats were obtained from the Department of Biochemistry, University of Jos, Nigeria. The rats were fed commercial feed and water ad libitum. Thirty-two rats with average body weight of 100 g were sorted at random into 4 groups. The four groups were treated as follows: Diabetes induced given normal saline; Diabetes induced given Nono; diabetes not induced given normal saline and diabetes not induced given Nono.
Diabetes was induced in the rats by intraperitonial injection of alloxan monohydrate dissolved in distilled water at a concentration of 100 mg kg-1 body weight. Diabetic situation was confirmed established before experimentation progressed. Administration of Nono was by oral intubation at 1 mL per rat thrice daily for 4 weeks. Groups not receiving Nono received 1 mL of normal saline per rat to equilibrate the stress of the treatment.
The method of Usman and Hosono (2000) was employed to collect blood samples from the tip of the tail of each rat which was used to determine the plasma glucose on a weekly basis. Plasma glucose concentration was determined by the method of Trinder (1969). At the end of the fourth week of nono administration the rats were sacrificed and the organs (kidney, heart and liver) were removed and preserved for the determination of total protein, lipid and cholesterol concentrations. Total protein in the serum and tissue homogenates was determined by the method of Mao and Tucci (1991). Total lipid and cholesterol in plasma and tissue homogenates were determined enzymatically with a commercial kit (Biosystem, SA.) The standard error of means of the different values was determined.
RESULTS AND DISCUSSION
Successful establishment of diabetes raised plasma glucose concentration to over 250 mg dL-1 from 100 mg dL-1 after induction by alloxan in rats (Fig. 1). This is expected (Mitchell, 2005). Diabetic rats fed with Nono had their plasma glucose concentration restored to the level of the control rats in which diabetes were not induced by the fourth week of feeding with Nono; while the plasma glucose concentration in non-diabetic rats suffered a slight reduction when fed with Nono (Fig. 1). This confirms the work of Tabuchi et al. (2003b), which reported hypoglycemic effects in rats fed with cells of lactic acid bacteria. It is thus conceivable that the Nono effect may be a function of its lactic acid bacteria component which was recorded at an average of 2.04x106 mL-1 (range = 1.16-4.0x106).
The diabetic rats had significantly lower tissue protein and a concomitant raised plasma protein level relative to the non diabetic rats. This again is expected (William, 1999). Nono by the 4th week of feeding restored the protein level to the level of non diabetic rats (Table 1).
Hyperlipidemia and hypercholesterolemia are characteristic features of diabetes (Baggio and Drucker, 2006). Lipids and cholesterol have been reported to also accumulate in the tissues of the heart, liver and kidney. Table 2 and 3 show increased concentration of lipids and cholesterol in the organ tissues and the plasma of the diabetic animals. However, administration of Nono had significant hypolipidemic and hypocholesterolemic effect in both the plasma and the organs of diabetic rats by the 4th week of feeding.
![]() | |
Fig. 1: | Plasma glucose concentration in diabetic rats fed with Nono |
Table 1: | Total protein concentration (mg g-1) in selected organs and plasma (mg dL-1) in diabetic rats administered fermented milk (Nono) at 4 weeks of feeding |
![]() | |
Each value is the mean of determinations from the eight rats in each treatment group±SEM. Values with different notations are significantly different (p≤0.05) |
Table 2: | Total lipid concentration (mg g-1) in selected organs and plasma (mg dL-1) of alloxan-induced diabetic rats administered fermented milk (Nono) at 4 weeks of feeding |
![]() | |
Each value is the mean of determinations from the eight rats in each treatment group±SEM. Values with different notations are significantly different (p≤0.05) |
Table 3: | Cholesterol concentration (mg g-1) in selected organs and plasma (mg dL-1) of alloxan-induced diabetic rats administered fermented milk (Nono) at 4 weeks of feeding |
![]() | |
Each value is the mean of determination from the eight rats in each treatment group±SEM. Values with different notations are significantly different (p≤0.05) |
The alterations in the protein, lipid and cholesterol concentrations in the organ tissues and the plasma are consequential on plasma hyperglycemic situation of diabetes. A control of the blood sugar is likely to result in normalization of the concentration of these other compounds. This apparently is what happened with the significant reduction in the plasma glucose concentration of the diabetic rats fed with Nono. It has been suggested that the chronic presence of LAB in the intestine through daily consumption of bacteria as in this study is needed for a long term effect on metabolism (St-Onge et al., 2000). Increase in the population of LAB in the intestine as a result of the administration of Nono may result in increased demands for glucose for normal energy requirement of these organisms to run their metabolic activities. This may lead to a decrease in the glucose concentration released into the serum and the various organs of the animals.
The hypocholesterolemic effect observed may also be as a result of the increased excretion of bile acids due to deconjugation activities of the LAB in Nono to produce free bile acids. Xiao et al. (2003) explained that serum cholesterol level decreases when a component suppresses resorption of bile acid. Nono is produced through natural fermentation without use of pure starter culture except fortuitous inoculation from previous fermentations (Akinyanju, 1989; Savadogo et al., 2004). Thus, this research indicates that wild strains of LAB in fermented milk may be capable of reversing diabetic situation. Further work is required to elucidate the mechanism of diabetic control by lactic acid bacteria containing foods.
ACKNOWLEDGMENTS
This research was supported by a research grant of Adekunle Ajasin University, Akungba-Akoko, Nigeria.
REFERENCES
- Aderiye, B.I. and S.A. Laleye, 2003. Relevance of fermented food products in South West Nigeria. Plant Foods Hum. Nutr., 58: 1-16.
CrossRefDirect Link - Akalin, S.A., S. Gunk and S. Duel, 1997. Influence of yoghurt and acidophilus yoghurt on serum cholesterol levels in mice. J. Dairy Sci., 80: 2721-2725.
Direct Link - Baggio, L.L. and D.J. Drucker, 2006. Therapeutic approaches to preserve Islets mass in type 2 diabetes. Annu. Rev. Med., 57: 265-281.
CrossRefDirect Link - Laleye, S.A., B.I. Aderiye and O. Akele, 2007. Hypocholesterolemic activity of nono in albino rats. Int. J. Dairy Sci., 2: 393-397.
CrossRefDirect Link - Mao, S.J.T. and M.A. Tucci, 1991. A colorimetric assay for measuring the lysis of a plasma clot. Anal. Biochem., 192: 6-10.
PubMedDirect Link - Mitchell, A.L., 2005. How obesity causes diabetics Not a tall tale. Science, 307: 373-375.
CrossRefDirect Link - Savadogo, A., C.A.T. Ouattara, P.W. Savadogo, A.S. Ouattara, N. Barro and A.S. Traore, 2004. Microorganisms involved in Fulani traditional fermented milk in Burkina Faso. Pak. J. Nutr., 3: 134-139.
CrossRefDirect Link - St-Onge, M.P., E.R. Farnworth and P.J. Jones, 2000. Consumption of fermented and non-fermented dairy products: Effect on cholesterol concentration and metabolism. Am. J. Clin. Nutr., 71: 674-681.
Direct Link - Tabuchi, M., A. Tamura, N. Yamada, T. Ishida, M. Hosoda and A. Hosono, 2003. Hypocholesterolemic effect of Lactobacillus GG in hypercholesterolemic rat. Milchwissenchaft, 58: 246-249.
Direct Link - Tabuchi, M., M. Ozaki, A. Tamura, N. Yamada, T. Ishida, M. Hosoda and A. Hosono, 2003. Antidiabetic effect of Lactobacillus GG in Streptozotocin-induced diabetic rats. Biosci. Biotechnol. Biochem., 67: 1421-1424.
PubMedDirect Link - Trinder, P., 1969. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem., 6: 24-27.
CrossRefDirect Link - Xiao, J.Z., S. Kondo, N. Takahashi, K. Miyaji, K. Oshida, A. Hiramatsu, K. Iwatsuki, S. Kokubo and A. Hosono, 2003. Effect of milk products fermented by Bifidobacterium longum on blood lipids in rats and adult male volunteers. J. Dairy Sci., 86: 2452-2461.
Direct Link